Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2

Detection Principle
NucleicAcid-PCR based
N2, E (Cepheid Xpert); RdRP (Abbott ID NOW); N gene (GenMark ePlex); ORF1ab (Hologic)
Testing Method Category
Testing Method
Testing Method - Additional Info
Evaluation of three platforms using Hologic Panther Fusion as reference: Cepheid Xpert® Xpress SARS-CoV-2 [Xpert Xpress], Abbott ID NOW COVID-19 [ID NOW], GenMark ePlex® SARS-CoV-2 Test [ePlex]
Reported Performance
LOD: 20,000 copies/mL (ID NOW), 1,000 copies/mL (ePlex), 100 copies/mL (Xpert Xpress); Positive Percent Agreement: 98.3% (Xpert), 91.4% (ePlex), 87.9% (ID NOW); Negative Percent Agreement: 100%
Sample Size
108 samples

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements